3 completed, 3 terminated, 1 recruiting, 1 unknown. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 3, Terminated 3, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Cloxacillin: new trials by email Literature Review of Cloxacillin trials Research Report on Cloxacillin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Continuous Antibiotic Infusion In Children Benzylpenicillin - Infection | Phase 3 | Recruiting | Tampere University Hospital | 150 | 2026-04-21 | 2026-05-08 |
| Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia Tab. Trimethoprim-sulfamethoxazole, Tab. Clindamycin, Tab. Cephalexin, or Tab. Linezolid, IV Cloxacillin, IV Cefazolin, IV Vancomycin, or IV Ceftaroline - Staphylococcus Aureus Bacteremia | Phase 3 | Unknown | Clinical Research Centre, Malaysia | 290 | 2024-06-28 | 2024-07-05 |
| Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection Beta-Lactam - Methicillin-Resistant Staphylococcus Aureus | Phase 3 | Terminated | Menzies School of Health Research | 358 | 2015-08-26 | 2018-12-19 |
| A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial Telavancin, Vancomycin, Daptomycin - Bacteremia | Phase 3 | Terminated | Cumberland Pharmaceuticals | 121 | 2014-12-01 | 2020-02-17 |
| Staphylococcus Aureus Bacteremia Antibiotic Treatment Options Trimethoprim-Sulfamethoxazole, Clindamycin, Linezolid - Staphylococcus Aureus Infection | Phase 3 | Completed | Heinrich-Heine University, Duesseldorf | 215 | 2013-12-01 | 2020-05-27 |
| Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus. Cloxacilin, Cloxacillin, Levofloxacin - Staphylococcus | Phase 3 | Terminated | Fundación Pública Andaluza Progreso y Salud | 1 | 2013-05-01 | 2015-08-07 |
| Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections Daptomycin, Vancomycin or Semi-Synthetic Penicillins (SSPs) - Infections | Phase 3 | Completed | Novartis Pharmaceuticals | 120 | 2010-03-01 | 2012-07-13 |
| Use of Probiotic Lactobacilli for the Treatment of Lactational Mastitis Lactobacillus salivarius HN6, Lactobacillus reuteri CR20, Lactobacillus fermentum LC40 - Mastitis | Phase 2 / Phase 3 | Completed | Universidad Complutense de Madrid | 300 | 2008-07-01 | 2009-05-25 |
Staphylococcal Infections (3) · Bacteremia (2) · Infections (2) · Sepsis (2) · Breast Feeding (1) · Cellulitis (1) · Disease Susceptibility (1) · Mastitis (1) · Osteomyelitis (1) · Short Stature, Auditory Canal Atresia, Mandibular Hypoplasia, Skeletal Abnormalities (1) · Soft Tissue Infections (1)
Clinical Research Centre, Malaysia (1) · Cumberland Pharmaceuticals (1) · Fundación Pública Andaluza Progreso y Salud (1) · Heinrich-Heine University, Duesseldorf (1) · Menzies School of Health Research (1) · Novartis Pharmaceuticals (1) · Tampere University Hospital (1) · Universidad Complutense de Madrid (1)
Spain (4) · Germany (2) · Australia (1) · Austria (1) · Finland (1) · France (1) · Israel (1) · Italy (1) · Malaysia (1) · Netherlands (1) · New Zealand (1) · Russia (1) · Singapore (1) · United Kingdom (1) · United States (1)
Achim J Kaasch, MD (1) · Joshua Davis, MBBS, FRACP (1) · Steven Tong, MBBS, FRACP (1)
PMID 20455694, PMID 24880136, PMID 26452342, PMID 27029920, PMID 32044943, PMID 32051007, PMID 38244557
2009 (1), 2025 (1)